BioSpace News Archive

Accelerated Enrollment Solutions ( AES ), a business of PPD, Inc. (Nasdaq: PPD ), and Science 37 , a leader in virtual clinical trials, are collaborating to recruit and enroll clinical trial participants who live beyond the geographic location of tr

John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB), a global leader in research and education, today announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases.

Celularity Inc. (“Celularity” or the “Company”), a clinical-stage company developing allogeneic cellular therapies from human placentas, today announced the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for the use of its proprietary CYNK-001 in adults with COVID-19.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced its joint venture entity with Voltron Therapeutics, Inc., HaloVax, has entered into a Sponsored Research Agreement with the Vaccine and Immunotherapy Center (VIC) of the Massachusetts General Hospital (MGH).

In response to the rapid escalation in COVID-19 related mental health issues, Espyr, an industry leader in mental health solutions, will begin offering its highly effective iResolve tele-mental health solution to help employers provide immediate support for employee mental health issues.

Ennaid Therapeutics, LLC, a specialty pharmaceutical company that uses its artificial intelligence (AI)-based drug discovery platforms to develop antiviral drugs, today announced that it is advanci

The National Center for Manufacturing Sciences (NCMS) is pleased to announce a new partnership with the Department of Defense (DOD) and the Federal Emergency Management Agency (FEMA) to support the critical shortage of medical equipment and supplies. Tapping into our significant network of American manufacturers, and working al

The COVID-19 pandemic and the historic federal, state, and local government efforts to mitigate its spread has stopped the economy in its tracks

The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis.

Sorrento Therapeutics, Inc. announced it has initiated the next phase of its collaboration with Celularity, Inc., a Warren, New Jersey, based clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies derived from the postpartum human placenta.